Cargando…
Clinically relevant reductions in HbA(1c) without hypoglycaemia: results across four studies of saxagliptin
BackgroundIn four 24-week controlled studies, the antihyperglycaemic efficacy of saxagliptin was demonstrated in patients with type 2 diabetes mellitus as add-on therapy to glyburide, a thiazolidinedione, or metformin, and when used in initial combination with metformin vs. metformin monotherapy in...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons Ltd.
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3842088/ https://www.ncbi.nlm.nih.gov/pubmed/23795975 http://dx.doi.org/10.1111/ijcp.12212 |